Definitive Healthcare Past Earnings Performance
Past criteria checks 0/6
Definitive Healthcare's earnings have been declining at an average annual rate of -81.5%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 24.9% per year.
Key information
-81.5%
Earnings growth rate
-61.0%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 24.9% |
| Return on equity | -24.2% |
| Net Margin | -80.5% |
| Next Earnings Update | 07 May 2024 |
Recent past performance updates
Recent updates
Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now
Apr 14
Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25
Mar 19Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?
Feb 16An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued
Dec 29Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Nov 24Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Jun 02Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 06A Look At The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Dec 08Definitive Healthcare Grows Headcount Despite Gathering Recession Clouds
Aug 31Definitive Healthcare Corp.'s (NASDAQ:DH) Intrinsic Value Is Potentially 27% Above Its Share Price
Jul 17Definitive Healthcare: No Involvement Yet Here
Jun 05Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Apr 01Definitive Healthcare: Getting Healthier
Jan 20A Look At The Intrinsic Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Dec 15Definitive Healthcare: Definitely Not For Me Here
Sep 24Revenue & Expenses BreakdownBeta
How Definitive Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 251 | -202 | 153 | 42 |
| 30 Sep 23 | 246 | -182 | 153 | 41 |
| 30 Jun 23 | 238 | -14 | 151 | 39 |
| 31 Mar 23 | 232 | -11 | 146 | 38 |
| 31 Dec 22 | 223 | -7 | 141 | 35 |
| 30 Sep 22 | 208 | -27 | 133 | 31 |
| 30 Jun 22 | 194 | -32 | 120 | 26 |
| 31 Mar 22 | 179 | -16 | 105 | 22 |
| 31 Dec 21 | 166 | -18 | 89 | 19 |
| 30 Sep 21 | 153 | -8 | 74 | 16 |
| 30 Jun 21 | 140 | 0 | 62 | 14 |
| 31 Mar 21 | 128 | 2 | 53 | 12 |
| 31 Dec 20 | 118 | 0 | 49 | 11 |
| 31 Dec 19 | 86 | -36 | 37 | 7 |
Quality Earnings: DH is currently unprofitable.
Growing Profit Margin: DH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DH is unprofitable, and losses have increased over the past 5 years at a rate of 81.5% per year.
Accelerating Growth: Unable to compare DH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).
Return on Equity
High ROE: DH has a negative Return on Equity (-24.15%), as it is currently unprofitable.